Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company lifted its holdings in Viemed Healthcare, Inc. (NASDAQ:VMDFree Report) by 14.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,918 shares of the company’s stock after acquiring an additional 1,912 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Viemed Healthcare were worth $98,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in VMD. Vanguard Group Inc. raised its holdings in Viemed Healthcare by 53.0% in the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock worth $16,803,000 after purchasing an additional 617,009 shares during the period. Kent Lake Capital LLC acquired a new stake in Viemed Healthcare in the 1st quarter valued at $5,557,000. Renaissance Technologies LLC grew its stake in Viemed Healthcare by 50.9% in the 2nd quarter. Renaissance Technologies LLC now owns 438,700 shares of the company’s stock valued at $2,873,000 after acquiring an additional 147,900 shares during the period. Paradigm Capital Management Inc. NY increased its holdings in Viemed Healthcare by 25.0% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 400,000 shares of the company’s stock worth $2,620,000 after acquiring an additional 80,000 shares in the last quarter. Finally, Raffles Associates LP raised its position in Viemed Healthcare by 4.3% during the second quarter. Raffles Associates LP now owns 362,691 shares of the company’s stock worth $2,376,000 after acquiring an additional 15,000 shares during the period. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

VMD opened at $9.19 on Monday. The company has a market cap of $356.85 million, a price-to-earnings ratio of 38.29 and a beta of 1.47. The firm’s fifty day simple moving average is $7.69 and its two-hundred day simple moving average is $7.41. The company has a quick ratio of 1.29, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Viemed Healthcare, Inc. has a 52-week low of $5.90 and a 52-week high of $10.44.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.03). Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%. The company had revenue of $54.97 million during the quarter.

About Viemed Healthcare

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

Further Reading

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMDFree Report).

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.